Beatrice Del Bello

Dr. Beatrice Del Bello


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Stroke
Verified
Journal Article
Closed access
BBBeatrice Del Bello
Beatrice Del Bello
ERElisa Rognone
Elisa Rognone
APAnna Pichiecchio
Anna Pichiecchio
ACAnna Maria Cavallini
Anna Maria Cavallini
FMFederico Mazzacane
Federico Mazzacane

7 July 2026 in Journal of the American Heart Association
Verified
Journal Article
Closed access
FBFrancesco Bax
Francesco Bax
MVMariarosaria Valente
Mariarosaria Valente
FMFederico Mazzacane
Federico Mazzacane
MFMatteo Foschi
Matteo Foschi
RORaffaele Ornello
Raffaele Ornello
LDLucio D'Anna
Lucio D'Anna
Background: Stress hyperglycemia (SHG) is associated with worse clinical outcomes in minor ischemic stroke. Hemorrhagic transformation (HT) represents a potential mechanism mediating this association, but clear characterization of this relationship is lacking. We therefore aimed to investigate whether HT mediates the effect of SHG on functional outcomes in patients with minor stroke. Methods: This was a prospective international cohort study (5 comprehensive stroke centers, Italy/United Kingdom). Individuals presenting with National Institutes of Health Stroke Scale ≤5, prestroke modified Rankin Scale ≤1, and without large vessel occlusion between January 2022 and December 2023 were included. SHG was assessed ≤24 hours using the glucose‐to‐glycated hemoglobin ratio. HT ≤7 days was classified in hemorrhagic infarction and parenchymal hematoma. Causal mediation was used to estimate SHG effect on modified Rankin Scale ≥2 at 3 months mediated by HT. Effect modification of age, diabetes, C‐reactive protein, and intravenous thrombolysis was explored. Results: There were 1316 patients included (mean age 69.6±12.7 years, 837 men [63.6%]). Higher glucose‐to‐glycated hemoglobin ratio quartiles were associated with modified Rankin Scale ≥2 (adjusted odds ratio [OR], 1.72 [95% CI, 1.24–2.40]; P =0.001) and HT severity (adjusted OR, 2.32 [95% CI, 1.43–3.76]; P =0.001). A significant proportion (14.8%) of the SHG effect on mRS was mediated by HT (average causal mediation effect, 0.014 [95% CI, 0.003–0.030]; P =0.006). Effect modification was found for younger age (≈60 years old), higher C‐reactive protein (≈7 mg/L), and absence of diabetes, but not for intravenous thrombolysis use. Conclusions: In patients with minor stroke, HT significantly mediated the effect of SHG on unfavorable outcome. The mediating effect of HT was greater in patients either ≈60 years old, without diabetes, or with high baseline C‐reactive protein levels. These initial results might inform patient selection for future interventional studies.

28 November 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SMStefano Mombelli
Stefano Mombelli
CRChiara Rinaldi
Chiara Rinaldi
AMAndrea Morotti
Andrea Morotti
SFStefano Forlivesi
Stefano Forlivesi
CBChiara Bassi
Chiara Bassi
FAFrancesco Arba
Francesco Arba
Introduction: Hyperglycemia is a common finding in patients with acute ischemic stroke and has been associated with poor outcomes, but its relationship with stroke severity at presentation is unclear. We investigated the associations between blood glucose levels and stroke severity in patients with acute small subcortical infarct (SSI). Methods: We retrospectively reviewed records of consecutive patients with acute SSI admitted to six Stroke Units. Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS). Outcomes of interest were as follows: NIHSS ≥ 7 at admission; increasing NIHSS quartiles at discharge. Independent associations between baseline glucose levels and stroke severity at presentation and discharge were assessed with logistic and ordinal regression, adjusting for age, sex, hypertension, diabetes, smoke exposure, and functional independence. Results: We included 792 patients: mean (±SD) age of 69.8 (±13) years, 548 (69%) males, median (IQR) NIHSS = 4(2–6). The mean blood glucose level at admission was 130 (±59) mg/dL. Patients with moderate–severe NIHSS had higher baseline blood glucose levels compared to those with lower NIHSS (148 mg/dL vs. 125 mg/dL, p < 0.001). After adjusting for confounders, glucose levels ≥ 130 mg/dL and the highest blood glucose quartile were associated with baseline NIHSS ≥ 7 (OR = 1.61; 95%CI = 1.04–2.51; OR = 1.80; 95%CI = 1.13–2.89, respectively). Glucose levels ≥ 130 mg/dL and the highest blood glucose quartile were associated with a shift towards higher NIHSS at discharge (cOR = 1.54; 95%CI = 1.11–2.14; cOR = 1.61; 95%CI = 1.14–2.29, respectively). Conclusions: In patients with acute SSI, higher blood glucose levels are associated with greater stroke severity at both admission and discharge, suggesting a potential biological link between blood glucose and the severity of SSI.

6 July 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
FFFederica Ferrari
Federica Ferrari
NLNicola Davide Loizzo
Nicola Davide Loizzo
FMFederico Mazzacane
Federico Mazzacane
BBBeatrice Del Bello
Beatrice Del Bello
SCSalvatore Console
Salvatore Console
ACAnna Maria Cavallini
Anna Maria Cavallini
Background/Objectives. Neurofilament light chain (NfL) is a biomarker of axonal injury with prognostic value in acute ischemic stroke and a promising surrogate outcome marker. This study evaluated whether serum NfL concentrations in ischemic stroke were modified by varying degrees of renal function. Methods. In this prospective, single-center observational study, patients aged 18–80 y admitted to the IRCCS Mondino Foundation—Stroke Unit between May 2022 and August 2024 were enrolled. Inclusion criteria were: radiologically confirmed ischemic stroke within 24 h of onset, NIHSS ≥ 1 at admission, pre-stroke mRS < 2, no other neurological comorbidities, and eGFR > 30 mL/min/1.73 m2. Serum creatinine was measured on admission, and eGFR was calculated using the CKD-EPI equation. Serum NfL was measured by Ella™ immunoassay at T0 (≤24 h), T1 (5 ± 3 d), and T2 (7 ± 3 d). Factors associated with serum NfL concentrations were assessed using linear mixed-effects models, and prognostic associations were evaluated by multivariate logistic regression. Results. Ninety-seven patients were included (median age 68.3 y; 39.2% female). Higher NfL levels were independently associated with lower eGFR (−2.4% per mL/min/1.73 m2 increase; 95% CI −3.2% to −1.6%; p < 0.001), and higher NIHSS at admission (+3.5% per point; 95% CI 0.7% to 6.4%; p = 0.014). Time from stroke onset was also associated with NfL (p < 0.001). Among patients with 3-month follow-up and T2 measurement (n = 62), the main effects of log10-transformed NfL at T2 and eGFR were not independently associated with unfavorable outcomes. However, a significant log10 NfL × eGFR interaction was observed (OR 0.22; 95% CI 0.07–0.73; p = 0.014), indicating that the prognostic association of NfL varied according to renal function. Conclusions. Renal function affects serum NfL after ischemic stroke and appears to modify its prognostic association with 3-month outcomes.